Chargement en cours...
Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
PURPOSE: The 2018 American Urological Association guidelines on the Evaluation and Management of Testosterone Deficiency recommended that 300 ng/dL be used as the threshold for prescribing testosterone replacement therapy (TRT). However, it is not uncommon for men to present with signs and symptoms...
Enregistré dans:
| Publié dans: | Int Braz J Urol |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Sociedade Brasileira de Urologia
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6844348/ https://ncbi.nlm.nih.gov/pubmed/31408289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1677-5538.IBJU.2019.0132 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|